|
|
Article: New inflammation study findings have been published by S.A. Boehme and colleagues.
- Article from:
- Biotech Week
- Article date:
- February 25, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
"A FITC-induced allergic contact hypersensitivity model was used to investigate the role that the prostaglandin D-2 receptor-chemoattractant receptor-homologous molecule expressed on T(h)2 cells (CRTH2) plays in modulating cutaneous inflammation. Our results show that inhibition of CRTH2, achieved via administration of a potent, small molecule antagonist, Compound A (Cmpd A), effectively blocked edema formation and greatly reduced the inflammatory infiltrate and skin pathology observed in drug vehicle-treated animals," scientists writing in the journal International Immunology report (see also Inflammation).
"Gene expression analysis revealed that Cmpd A ...
Related newspaper, magazine, and journal articles:
|
|
Article: National Biotech Week observed in last week of ...
Manila Bulletin;
November 16, 2007 ;
700+ words
...Byline: MARVYN N. BENANING President Arroyo has proclaimed the last week of November as the annual National Biotechnology Week. Proclamation No. 1414, which was endorsed by seven Cabinet secretaries led by Agriculture Secretary Arthur Yap, was formally signed this week. Arroyo also created the
|
|